Application Nr Approved Date Route Status External Links
ANDA206251 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Aripiprazole Tablets Are Indicated For The Treatment Of: Schizophrenia [See Clinical Studies (14.1) ] Additional Pediatric Use Information Is Approved For Otsuka America Pharmaceutical, Inc.’s Abilify ® (Aripiprazole) Product. However, Due To Otsuka America Pharmaceutical, Inc.’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Information. Aripiprazole Is An Atypical Antipsychotic. The Oral Formulations Are Indicated For: Schizophrenia (14.1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Aripiprazole ARIPIPRAZOLE ZINC1851149

Comments